A5010228323- Graphene and Nanomaterials Applications
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Nanoplatforms for cancer theranostics
- Carbon and Quantum Dots Applications
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
2021-2024
Universidade do Porto
2021-2024
Nonmelanoma skin cancer (NMSC) is the most common worldwide, among which 80% basal cell carcinoma (BCC). Current therapies' low efficacy, side effects, and high recurrence highlight need for alternative treatments. In this work, a partially reduced nanographene oxide (p-rGOn) developed in our laboratory was used. It has been achieved through controlled reduction of via UV–C irradiation that yields small nanometric particles (below 200 nm) preserve original water stability while acquiring...
Nanostructured carriers have been widely used in pharmaceutical formulations for dermatological treatment. They offer targeted drug delivery, sustained release, improved biostability, and low toxicity, usually presenting advantages over conventional formulations. Due to its large surface area, small size photothermal properties, graphene oxide (GO) has the potential be such applications. Nanographene (GOn) presented average sizes of 197.6 ± 11.8 nm, a charge -39.4 1.8 mV, being stable water...
Nanostructured carriers have been widely used in pharmaceutical formulations for dermatological treatment. They offer targeted drug delivery, sustained release, improved biostability, and low toxicity, usually presenting advantages over conventional formulations. Due to its large surface area, small size photothermal properties, graphene oxide (GO) has the potential be such applications. Nanographene (GOn) presented average sizes of 197.6 ± 11.8 nm, a charge -39.4 1.8 mV, being...